A methylation assay for the detection of non‐muscle‐invasive bladder cancer (NMIBC) recurrences in voided urine
Tahlita C.M. Zuiverloon(Erasmus MC), Ellen C. Zwarthoff(Erasmus MC), Jesrael R. Munoz, Marinus J.C. Eijkemans(Erasmus University Rotterdam), Kirstin A. van der Keur(Erasmus MC Cancer Institute), Willemien Beukers(Erasmus University Rotterdam), Chris H. Bangma(Erasmus MC), Jan P. Schouten(University Hospital Foundation), Hester F. Lingsma(Erasmus MC)
Cited by 68
Related Papers
Internal validation of predictive models
|Journal of Clinical Epidemiology|2001|2.6k
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.3k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
Substantial effective sample sizes were required for external validation studies of predictive logistic regression models
|Journal of Clinical Epidemiology|2005|644